JF
MRSN

Jump Financial’s Mersana Therapeutics MRSN Stock Holding History

Jump Financial’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-453
Closed -$3.35K – 2050
2025
Q2 		$3.35K Buy
+453
New +$3.98K ﹤0.01% 1742
2024
Q3 		– Sell
-3,222
Closed -$162K – 1943
2024
Q2 		$162K Buy
3,222
+2,572
+396% +$186K ﹤0.01% 1590
2024
Q1 		$72.8K Buy
+650
New +$64.6K ﹤0.01% 1816
2023
Q3 		– Sell
-896
Closed -$73.7K – 2110
2023
Q2 		$73.7K Buy
+896
New +$131K ﹤0.01% 1694
2023
Q1 		– Sell
-2,585
Closed -$379K – 1880
2022
Q4 		$379K Buy
2,585
+801
+45% +$135K 0.02% 902
2022
Q3 		$301K Buy
+1,784
New +$290K 0.01% 1148
2022
Q2 		– Sell
-2,700
Closed -$269K – 1864
2022
Q1 		$269K Sell
2,700
-216
-7% -$25.2K 0.01% 1128
2021
Q4 		$453K Buy
+2,916
New +$567K 0.03% 700
2021
Q2 		– Sell
-1,013
Closed -$409K – 1285
2021
Q1 		$409K Buy
+1,013
New +$491K 0.04% 482

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return